Potential anti-cancer effect of N-hydroxy-7-(2-naphthylthio) heptanomide (HNHA), a novel histone deacetylase inhibitor, for the treatment of thyroid cancer-Reference-Cited by-同舟云学术

Potential anti-cancer effect of N-hydroxy-7-(2-naphthylthio) heptanomide (HNHA), a novel histone deacetylase inhibitor, for the treatment of thyroid cancer

Published:2015-12 Issue:1 Volume:15 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Kim Seok-Mo,Park Ki-Cheong,Jeon Jeong-Yong,Kim Bup-Woo,Kim Hyeung-Kyoo,Chang Ho-Jin,Choi Seung-Hoon,Park Cheong-Soo,Chang Hang-Seok

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s12885-015-1982-6

Reference42 articles.

1. Nikiforov YE. Thyroid carcinoma: molecular pathways and therapeutic targets. Mod Pathol. 2008;21 Suppl 2:S37–43.

2. Gullu BE, Celik O, Gazioglu N, Kadioglu P. Thyroid cancer is the most common cancer associated with acromegaly. Pituitary. 2010;13(3):242–8.

3. American Thyroid Association Guidelines Taskforce on Thyroid N, Differentiated Thyroid C, Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19(11):1167–214.

4. Smallridge RC. Approach to the patient with anaplastic thyroid carcinoma. J Clin Endocrinol Metab. 2012;97(8):2566–72.

5. Sun C, Li Q, Hu Z, He J, Li C, Li G, et al. Treatment and prognosis of anaplastic thyroid carcinoma: experience from a single institution in China. PLoS One. 2013;8(11):e80011.

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insights into lenvatinib resistance: mechanisms, potential biomarkers, and strategies to enhance sensitivity;Medical Oncology;2024-02-21

2. MHY446 induces apoptosis via reactive oxygen species-mediated endoplasmic reticulum stress in HCT116 human colorectal cancer cells;Journal of Chemotherapy;2023-12-06

3. Epigenetic Targets and Their Inhibitors in Thyroid Cancer Treatment;Pharmaceuticals;2023-04-07

4. HDACs as an emerging target in endocrine tumors: a comprehensive review;Expert Review of Endocrinology & Metabolism;2023-03-04

5. Modern concepts of the molecular pathogenesis of thyroid cancer;Advances in Molecular Oncology;2021-07-28